المؤلفون: Pickering, Chad, Aiyetan, Paul, Gege Xu, Mitchell, Alan, Rice, Rachel, Najjar, Yana G., Markowitz, Joseph, Ebert, Lisa M., Brown, Michael P., Tapia-Rico, Gonzalo, Frederick, Dennie, Xin Cong, Serie, Daniel, Lindpaintner, Klaus, Schwarz, Flavio, Boland, Genevieve M.

المصدر: Frontiers in Immunology; 2023, p1-14, 14p

مصطلحات موضوعية: IMMUNE checkpoint inhibitors, IPILIMUMAB, ARTIFICIAL intelligence, MELANOMA, BIOMARKERS, METASTASIS, TURNAROUND time

المؤلفون: Eroglu, Zeynep, Holmen, Sheri L., Chen, Qing, Khushalani, Nikhil I., Amaravadi, Ravi, Thomas, Reena, Ahmed, Kamran A., Tawbi, Hussein, Chandra, Sunandana, Markowitz, Joseph, Smalley, Inna, Liu, James K. C., Chen, Yian Ann, Najjar, Yana G., Karreth, Florian A., Abate‐Daga, Daniel, Glitza, Isabella C., Sosman, Jeffrey A., Sondak, Vernon K., Bosenberg, Marcus

المصدر: Pigment Cell & Melanoma Research; May2019, Vol. 32 Issue 3, p458-469, 12p

مصطلحات موضوعية: CENTRAL nervous system, BRAIN metastasis, MELANOMA prognosis, CANCER patients, IMMUNOTHERAPY

المؤلفون: Najjar, Yana G., Kirkwood, John M.

المصدر: American Journal of Hematology/Oncology; Nov2014, Vol. 10 Issue 5, p17-19, 3p

مصطلحات موضوعية: THERAPEUTIC use of monoclonal antibodies, ENZYME inhibitors, MELANOMA, METASTASIS, MONOCLONAL antibodies, DRUG approval, DISEASE progression, IPILIMUMAB

الشركة/الكيان: UNITED States. Food & Drug Administration